Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganetespib + Docetaxel vs Docetaxel in Advanced NSCLC
NCT01348126Phase 3Terminated
- Sponsor
- Synta Pharmaceuticals Corp.
- Start
- May 2011
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of ganetespib in non-small cell lung cancer (NSCLC), sponsored by Synta Pharmaceuticals Corp.. Started May 2011; status: terminated.
02
Drugs
ganetespib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01348126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01348126.